| Domain structure and three-dimensional model of a group II intron-encoded reverse transcriptase FJH Blocker, G Mohr, LH Conlan, LI Qi, M Belfort, AM Lambowitz Rna 11 (1), 14-28, 2005 | 121 | 2005 |
| A three-dimensional model of a group II intron RNA and its interaction with the intron-encoded reverse transcriptase L Dai, D Chai, SQ Gu, J Gabel, SY Noskov, FJH Blocker, AM Lambowitz, ... Molecular cell 30 (4), 472-485, 2008 | 86 | 2008 |
| Construction and 3-D computer modeling of connector arrays with tetragonal to decagonal transition induced by pRNA of phi29 DNA-packaging motor YY Guo, F Blocker, F Xiao, P Guo Journal of nanoscience and nanotechnology 5 (6), 856-863, 2005 | 53 | 2005 |
| Correlation of MET gene amplification and TP53 mutation with PD-L1 expression in non-small cell lung cancer M Albitar, S Sudarsanam, W Ma, S Jiang, W Chen, V Funari, F Blocker, ... Oncotarget 9 (17), 13682, 2018 | 45 | 2018 |
| Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification S Agersborg, C Mixon, T Nguyen, S Aithal, S Sudarsanam, F Blocker, ... Breast Cancer Research and Treatment 170, 321-328, 2018 | 39 | 2018 |
| Hepatitis B virus direct repeat sequence: imino proton exchange rates and distance and torsion angle restraints from NMR KD Bishop, FJH Blocker, W Egan, TL James Biochemistry 33 (2), 427-438, 1994 | 17 | 1994 |
| Comparison of diagnostic methodologies to detect chromosomal abnormalities. C Wong, M Thangavelu, M Hibbard, F Blocker, LM Weiss, VA Funari Journal of Clinical Oncology 37 (15_suppl), e14617-e14617, 2019 | 3 | 2019 |
| IDH1 and IDH2: Founding or progressor mutations in myeloid neoplasms W Ma, I De Dios, V Funari, S Sudarsanam, SP Jiang, S Agersborg, ... Blood 130, 405, 2017 | 3 | 2017 |
| TP53/NPM1-mutated acute myeloid leukemia as a molecularly distinct disease entity. FJ Scarpa, M Paul, R Daringer, WA Wolfson, F Lopez Diaz, S Agersborg, ... Journal of Clinical Oncology 39 (15_suppl), 7030-7030, 2021 | 1 | 2021 |
| STAG2-mutated AML patients: ASXL1 cohesin binding motif status and mutation landscape. FJ Scarpa, M Paul, WA Wolfson, LM Weiss, VA Funari, F Blocker Journal of Clinical Oncology 38 (15_suppl), 7538-7538, 2020 | 1 | 2020 |
| Association between microsatellite instability and BRAF, TP53, PTEN, and KRAS mutations in colorectal cancer. M Albitar, S Sudarsanam, W Ma, S Jiang, W Chen, VA Funari, F Blocker, ... Journal of Clinical Oncology 36 (15_suppl), e15604-e15604, 2018 | 1 | 2018 |
| Standard DNA duplexes and RNA: DNA hybrids in solution U Schmitz, FJH Blocker, TL James Oxford Handbook of Nucleic Acid Structure, 253-294, 1999 | 1 | 1999 |
| Pattern of PIK3CA co-alterations in endometrial cancer M Paul, FJ Scarpa, R Daringer, S Agersborg, VA Funari, F Blocker Cancer Research 82 (12_Supplement), 2934-2934, 2022 | | 2022 |
| A novel comprehensive breakpoint-targeted assay for clinically actionable RNA fusions and aberrant RNAs in solid tumors FJ Lopez-Diaz, SP Rivera, C Ou, C Magnan, B Thomas, T Gyuris, Y Mou, ... Cancer Research 81 (13_Supplement), 2238-2238, 2021 | | 2021 |
| Different genomic mutations signatures are associated to specific PD-L1/TMB states on lung cancer with potential value for patients screening for immunotherapy FJ Lopez-Diaz, L Keeler, F Blocker, S Sprankles, R Bender, S Agersborg, ... Cancer Research 80 (16_Supplement), 3170-3170, 2020 | | 2020 |
| A comprehensive genomic profiling approach to interrogate hematologic malignancies using a novel multimodal next generation sequencing assay in a single-tube SC Jung, YX Yu, Y Mou, H Nam, C Wong, S Koo, B Thomas, F Blocker, ... Cancer Research 80 (16_Supplement), 182-182, 2020 | | 2020 |
| Role of epigenetic regulators in single-base substitution patterns in AML. M Paul, FJ Scarpa, WA Wolfson, L Weiss, VA Funari, F Blocker Journal of Clinical Oncology 38 (15_suppl), e19500-e19500, 2020 | | 2020 |
| Identifying new biomarkers and targeted molecules for immunotherapy using targeted RNA next generation sequencing. W Ma, I De Dios, VA Funari, M Sheikholeslami, N Stavrou, F Blocker, ... Journal of Clinical Oncology 36 (15_suppl), 3088-3088, 2018 | | 2018 |
| Mismatch repair deficiency testing for immune checkpoint therapy: Immunohistochemistry vs microsatellite instability. S Sudarsanam, F Blocker, S Agersborg, VA Funari, S Jiang, W Chen, ... Journal of Clinical Oncology 36 (15_suppl), 3022-3022, 2018 | | 2018 |
| Using Targeted Enrichment RNA Sequencing in the Diagnosis of Hematologic Neoplasms in Fresh and Paraffin-Embedded Tissue W Ma, I De Dios, V Funari, B Shahbaba, F Blocker, M Albitar Blood 130, 5118, 2017 | | 2017 |
